Correlation Between Acumen Pharmaceuticals and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Ventyx Biosciences, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Ventyx Biosciences.
Diversification Opportunities for Acumen Pharmaceuticals and Ventyx Biosciences
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Acumen and Ventyx is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Ventyx Biosciences
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Ventyx Biosciences. In addition to that, Acumen Pharmaceuticals is 1.22 times more volatile than Ventyx Biosciences. It trades about -0.15 of its total potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.1 per unit of volatility. If you would invest 231.00 in Ventyx Biosciences on August 28, 2024 and sell it today you would lose (25.00) from holding Ventyx Biosciences or give up 10.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Ventyx Biosciences
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Ventyx Biosciences |
Acumen Pharmaceuticals and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Ventyx Biosciences
The main advantage of trading using opposite Acumen Pharmaceuticals and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
| Ventyx Biosciences vs. Capricor Therapeutics | Ventyx Biosciences vs. Soleno Therapeutics | Ventyx Biosciences vs. Bio Path Holdings | Ventyx Biosciences vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |